Cholbam FDA Approval History
FDA Approved: Yes (First approved March 17, 2015)
Brand name: Cholbam
Generic name: cholic acid
Dosage form: Capsules
Company: Asklepion Pharmaceuticals LLC
Treatment for: Bile Acid Synthesis Disorders
Cholbam (cholic acid) is a bile acid preparation for the treatment of patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders (including Zellweger spectrum disorders).
Development Timeline for Cholbam
|Mar 17, 2015||Approval FDA Approves Cholbam (cholic acid) for Rare Bile Acid Synthesis Disorders|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.